Firms
Norcliffe Capital
London, United Kingdom
Norcliffe Capital is a UK life-sciences investment and fundraising business focused on tax-efficient direct investments in medical technology and biotechnology companies. It connects high-net-worth investors, advisers and other capital providers with EIS/SEIS-eligible private-company opportunities and supports investees through due diligence, equity fundraising and commercial development. Its published portfolio includes neurovascular devices, brain-cancer diagnostics, biomaterials and molecular-analysis technology. The exact legal company is Norcliffe Capital Limited, UK number11181154, incorporated1February2018; its current website dates the operating brand to2020. FCA reference826977 is an appointed representative of Sturgeon Ventures LLP, reference452811, rather than a separately authorised regulated firm. The public model is direct company investment by clients, not a verified pooled55Mventurefund: the website’s55Mfundsraised is an aggregate firm claim with no exact fund/closingdate. Norcliffe Nominees is a distinct administrative nominee for underlying investors and is not automatically the manager’s own cash buyer.
- Founded
- 2018
- Type
- Venture capital
Funds0
No funds on record yet.
Team
Operations and support
 David OnionsChief Scientific Officer |
 Patricia ReynoldsDirector · Founder and Chief Executive Officer |
Co-investing
Oxford Science Enterprises
Oxford Endovascular£8M · 2024-05-20
Parkwalk Advisors- Oxford Endovascular£8M · 2024-05-20
University of Oxford- Oxford Endovascular£8M · 2024-05-20
Vulpes- Oxford Endovascular£8M · 2024-05-20